PL370704A1 - Cytotoksyczne białko i jego zastosowanie - Google Patents

Cytotoksyczne białko i jego zastosowanie

Info

Publication number
PL370704A1
PL370704A1 PL02370704A PL37070402A PL370704A1 PL 370704 A1 PL370704 A1 PL 370704A1 PL 02370704 A PL02370704 A PL 02370704A PL 37070402 A PL37070402 A PL 37070402A PL 370704 A1 PL370704 A1 PL 370704A1
Authority
PL
Poland
Prior art keywords
protein
cytotoxic protein
toxin
utilization
cytotoxic
Prior art date
Application number
PL02370704A
Other languages
English (en)
Inventor
Hiromitsu Saisho
Hideki Tanzawa
Hiroyuki Ohno
Original Assignee
Hiroyuki Ohno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hiroyuki Ohno filed Critical Hiroyuki Ohno
Publication of PL370704A1 publication Critical patent/PL370704A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/121—Helicobacter (G); Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02370704A 2001-12-05 2002-12-05 Cytotoksyczne białko i jego zastosowanie PL370704A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001371210 2001-12-05

Publications (1)

Publication Number Publication Date
PL370704A1 true PL370704A1 (pl) 2005-05-30

Family

ID=19180288

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370704A PL370704A1 (pl) 2001-12-05 2002-12-05 Cytotoksyczne białko i jego zastosowanie

Country Status (25)

Country Link
US (3) US7385035B2 (pl)
EP (1) EP1462457B1 (pl)
JP (1) JP4776166B2 (pl)
KR (1) KR100628917B1 (pl)
CN (1) CN1599750B (pl)
AT (1) ATE393164T1 (pl)
AU (1) AU2002354096B2 (pl)
BR (1) BR0215114A (pl)
CA (1) CA2469154C (pl)
CO (1) CO5590932A2 (pl)
DE (1) DE60226277T2 (pl)
ES (1) ES2305323T3 (pl)
HR (1) HRP20040442A2 (pl)
IL (1) IL162320A0 (pl)
IS (1) IS7270A (pl)
MA (1) MA27504A1 (pl)
MX (1) MXPA04005459A (pl)
NO (1) NO20042130L (pl)
NZ (1) NZ533797A (pl)
PL (1) PL370704A1 (pl)
RS (1) RS49804A (pl)
RU (1) RU2004117155A (pl)
TW (1) TW200303919A (pl)
WO (1) WO2003048199A1 (pl)
ZA (1) ZA200404209B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004357586A (ja) * 2003-06-04 2004-12-24 Hiroyuki Ono 細胞障害タンパク質ｍ毒素の発現方法
WO2007072576A1 (ja) * 2005-12-21 2007-06-28 Fourier Inc. ヘリコバクターピロリ由来ｍ毒素大量発現株の製造方法
US8151835B2 (en) * 2006-08-23 2012-04-10 Fht, Inc. Automated drug delivery bag filling system
CN113567671A (zh) * 2020-04-29 2021-10-29 南京农业大学 猪血管紧张素转化酶2(ace2)多克隆抗体的制备

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218158A3 (en) 1985-09-30 1988-12-07 Asahi Kasei Kogyo Kabushiki Kaisha Human monoclonal antibody, B-cell line for producing this antibody and method for preparing this B-cell line and antibody.
EP0232871A3 (en) 1986-02-07 1989-03-15 Yoshitomi Pharmaceutical Industries, Ltd. Human monoclonal antibody, hybridoma producing the same and its use
JPH0798000B2 (ja) 1987-05-23 1995-10-25 萩原 義秀 ガン関連抗原特異的ヒト免疫グロブリン
US5366865A (en) 1989-04-06 1994-11-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Anti-platelet monoclonal antibody
US6787153B1 (en) 1991-06-28 2004-09-07 Mitsubishi Chemical Corporation Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
US5660827A (en) 1992-03-05 1997-08-26 Board Of Regents, The University Of Texas System Antibodies that bind to endoglin
US6004555A (en) 1992-03-05 1999-12-21 Board Of Regents, The University Of Texas System Methods for the specific coagulation of vasculature
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5877289A (en) 1992-03-05 1999-03-02 The Scripps Research Institute Tissue factor compositions and ligands for the specific coagulation of vasculature
US6093399A (en) 1992-03-05 2000-07-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
CN1220703A (zh) * 1996-03-29 1999-06-23 阿斯特拉公司 与幽门螺杆菌及其疫备组合物有关的核酸和氨基酸序列
US6417337B1 (en) 1996-10-31 2002-07-09 The Dow Chemical Company High affinity humanized anti-CEA monoclonal antibodies
US6348581B1 (en) 1996-10-31 2002-02-19 The Dow Chemical Company High affinity humanized anti-TAG-72 monoclonalantibodies
ATE238774T1 (de) * 1997-10-09 2003-05-15 Dexcel Pharma Technologies Ltd Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
JP2000063280A (ja) * 1998-06-11 2000-02-29 Takeda Chem Ind Ltd 抗ヘリコバクタ―・ピロリ活性胃腸薬
RU2227752C2 (ru) 1998-11-12 2004-04-27 Новолитикс Инк. Способы перекрытия кровотока и композиции для их реализации
WO2001070955A2 (en) * 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes

Also Published As

Publication number Publication date
MXPA04005459A (es) 2004-10-11
EP1462457A4 (en) 2005-12-21
RU2004117155A (ru) 2005-05-10
IL162320A0 (en) 2005-11-20
US20060210575A1 (en) 2006-09-21
AU2002354096A1 (en) 2003-06-17
CO5590932A2 (es) 2005-12-30
AU2002354096B2 (en) 2007-05-24
NO20042130L (no) 2004-09-01
WO2003048199A1 (fr) 2003-06-12
EP1462457B1 (en) 2008-04-23
US20080233556A1 (en) 2008-09-25
HRP20040442A2 (en) 2004-12-31
KR20050044708A (ko) 2005-05-12
JPWO2003048199A1 (ja) 2005-04-14
IS7270A (is) 2004-05-17
CN1599750A (zh) 2005-03-23
DE60226277T2 (de) 2009-07-16
TW200303919A (en) 2003-09-16
MA27504A1 (fr) 2005-09-01
US7385035B2 (en) 2008-06-10
EP1462457A1 (en) 2004-09-29
JP4776166B2 (ja) 2011-09-21
US20090208972A1 (en) 2009-08-20
BR0215114A (pt) 2005-02-01
DE60226277D1 (de) 2008-06-05
ES2305323T3 (es) 2008-11-01
KR100628917B1 (ko) 2006-09-27
ATE393164T1 (de) 2008-05-15
CN1599750B (zh) 2010-05-12
CA2469154C (en) 2011-03-01
NZ533797A (en) 2008-07-31
CA2469154A1 (en) 2003-06-12
ZA200404209B (en) 2005-05-30
RS49804A (sr) 2006-10-27

Similar Documents

Publication Publication Date Title
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
WO2003031464A3 (en) Remodeling and glycoconjugation of peptides
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
ZA200708407B (en) IL-21 variants
IL153360A0 (en) Chemically-modified peptides, compositions, and methods of production and use
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
DK1379550T3 (da) Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser
IL136654A0 (en) Hemiasterlin analogs
DE59902827D1 (de) Azidfreie, gaserzeugende Zusammensetzung
DE69937570D1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
IL162320A0 (en) Catotoxic protein and utilization thereof
EP1279677A4 (en) GD3 MIMETIC PEPTIDES
SG185137A1 (en) Biologically active peptides
WO2003089590A3 (en) TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
MY126118A (en) Somatostatin analogs for the treatment of cancer
MXPA05004849A (es) Novedosas composiciones de multiples peptidos antigenicos relacionados con inhibina, que mejoran el desempeno de produccion avicola.
AU2000265052A1 (en) Somatostatin analogs for the treatment of cancer
PT1326982E (pt) Polipéptidos basb205 e polinucleótidos que os codificam
AU2003296543A1 (en) Peptides having a high cysteine content
ATE443715T1 (de) Polypeptide aus haemophilus influenza
MY117747A (en) Vasoactive intestinal peptide analogs
AU2003260539A1 (en) Anti-bacterial peptides, genes coding for peptides, transformed organisms, vectors, preparation thereof and compositions containing same
DE69919693D1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)